Efficacy of Acute Lymphoblastic Leukemia-Based Therapy in Treating Patients With Acute Leukemia of Ambiguous Lineage
Clinical trial NCT04440267 · RECRUITING
Trial details
- NCT number
- NCT04440267
- Sponsor
- Institute of Hematology & Blood Diseases Hospital, China
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-08
- Primary completion
- 2026-06-20
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.